The antidepressant sertraline prevents the behavioral and EEG changes induced in two animal models of seizures
Authors:
- María SitgesMSMaría Sitges
- Blanca I. AldanaBABlanca I. Aldana
- Carlos D. GómezCGCarlos D. Gómez
- Vladimir NekrassovVNVladimir Nekrassov
- 1 December 2012
- journal article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 25 (4) , 511-516
Abstract
No abstract availableKeywords
Funding Information
- IN207912
- PAPIIT
This publication has 25 references indexed in Scilit:
- Bidirectional link between epilepsy and psychiatric disordersNature Reviews Neurology, 2012
- Depression, stress, epilepsy and adult neurogenesisExperimental Neurology, 2012
- The impact of depression and anxiety disorder symptoms on the health‐related quality of life of children and adolescents with epilepsyEpilepsia, 2011
- Treatment of Depression in Patients with EpilepsyCurrent Treatment Options in Neurology, 2011
- Postictal affective episodesEpilepsy & Behavior, 2010
- An evidence-based review of the clinical use of sertraline in mood and anxiety disordersInternational Clinical Psychopharmacology, 2009
- Depression in epilepsy: a complex relation with unexpected consequencesCurrent Opinion in Neurology, 2008
- Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval ReportsBiological Psychiatry, 2007
- Effects of Psychotropic Drugs on Seizure ThresholdDrug Safety, 2002
- Pharmacological profile of antidepressants and related compounds at human monoamine transportersEuropean Journal of Pharmacology, 1997